Mark Avagliano G1 Therapeutics, Inc. (GTHX) insider trading activity
Mark Avagliano is Chief Business Officer of G1 Therapeutics, Inc.. Currently has a direct ownership of 244,683 shares of GTHX, which is worth approximately $628,835. The most recent transaction as insider was on Jul 01, 2024, when has been sold 35,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
245K
12.33%
3M change
217.13%
12M change
Total Value Held
$628,835
Mark Avagliano Transaction History
MA
Mark Avagliano
Chief Business Officer
Research Triangle Park, NC